UK Markets closed

Orchard Therapeutics plc (ORTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.2100-0.0700 (-5.47%)
At close: 04:00PM EST
1.2200 +0.01 (+0.83%)
After hours: 06:36PM EST
Sign in to post a message.
  • A
    Alexis
    Offering soon
  • P
    Paul B
    Put it on your 2021 Picks to Click at $8, downgrade at $1.60. Now that’s some Wealth Management JPM!
  • J
    Johnie
    Could it go below 0?
  • P
    PaulN1958
    Sorry Longs. I am not Short; but ORTX is a #$%$I've been warning you for a long time.ORTX focuses on diseases with Very Very Low Prevalences of 1 in 40,000, with Very Very Small markets of 0.001% of the population, and as a result it has Very Very low profitability.52 week high: $9.0852 week low: $1.51% Change: -83.4%
  • P
    PaulN1958
    ORTX DOWNGRADED TO SELL

    P Morgan analyst Anupam Rama downgrades Orchard Therapeutics (NASDAQ:ORTX) from Neutral to Underweight.
  • F
    Fed
    Investor conference on Monday. Load up buddy
  • Y
    Yahoo Finance Insights
    Orchard Therapeutics reached an all time low at 1.25
  • A
    Andy
    Downgraded today by JP Morgan and down over 9% premarket right now. What a cluster this stock is.

    https://www.streetinsider.com/dr/news.php?id=19222048
    UPDATE: JPMorgan Downgrades Orchard Therapeutics (ORTX) to Underweight on Lack of Meaningful Short-term Catalysts and Negative Sentiment
    www.streetinsider.com
  • P
    PaulN1958
    Orchard Therapeutics downgraded to underweight from neutral at J.P. Morgan
  • P
    PaulN1958
    ORTX DOWNGRADED TO SELL

    P Morgan analyst Anupam Rama downgrades Orchard Therapeutics (NASDAQ:ORTX) from Neutral to Underweight.
  • S
    Sam
    This stock is almost trading at cash. Amazing.
  • A
    Andy
    Laugh of the day. Tip ranks has a price target of $11.
  • A
    Alexis
    Hope it goes closer to $1 to load size.
  • Y
    Yahoo Finance Insights
    Orchard Therapeutics reached an all time low at 1.47
  • P
    PaulN1958
    ORTX DOWNGRADED TO SELL

    JP Morgan analyst Anupam Rama downgrades Orchard Therapeutics (NASDAQ:ORTX) from Neutral to Underweight.
  • G
    GreenDay
    ORTX back to life?
  • P
    PaulN1958
    ORTX focuses on diseases with Very Very Low Prevalences of 1 in 40,000, with Very Very Small Markets of 0.001% of the Population, with Very Very Low Profitability.

    Do your Due Diligence.

    Illness % Pop Prevalence
    Breast Cancer (Female): 12.9000% , 1 in 8
    Prostate Cancer (Male): 12.5000% , 1 in 8
    Lung and Bronchus Cancer: 6.1000% , 1 in 16
    Cardiovascular disease: 5.4634% , 1 in 18
    Colorectal Cancer: 4.1600% , 1 in 24
    Uterine Cancer: 3.1000% , 1 in 32
    Bladder Cancer: 2.4000% , 1 in 42
    Melanoma of the Skin: 2.3000% , 1 in 43
    Non-Hodgkin Lymphoma: 2.1000% , 1 in 48
    Pancreatic cancer: 1.7000% , 1 in 59
    Kidney and Renal Pelvis Cancer: 1.7000% , 1 in 59

    Metachromatic leukodystrophy (ORTX): 0.0010% , 1 in 40,000 to 160,000
    Mucopolysaccharidosis type IIIA (MPS-IIIA)(ORTX): 0.0010% , 1 in 100,000 to 200,000
    Wiskott-Aldrich syndrome (ORTX): 0.0004% , 1 in 250,000
    Adenosine deaminase deficiency (ORTX): 0.0002% , 1 in 200,000 to 1,000,000
  • P
    PaulN1958
    ORTX DOWNGRADED TO SELL

    JP Morgan analyst Anupam Rama downgrades Orchard Therapeutics (NASDAQ:ORTX) from Neutral to Underweight.
  • A
    Alexis
    I’ll add 200,000 at $1
  • Y
    Yahoo Finance Insights
    Orchard Therapeutics reached an all time low at 1.40